BIOA stock

BioAge Labs, Inc (BIOA) earnings · rev $9.0M

These earnings events as JSON? API free 100/day

BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.

This BIOA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.

When the next BIOA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for BIOA. We will not invent a beat or miss.

Not investment advice. Full BIOA research stays on the stock page; the tape stays on the quote page.

BIOA earnings FAQ

What are BIOA's latest revenue and net income?

Latest cached BioAge Labs, Inc (BIOA) revenue for Dec 31, 2025 was $9.0M. Net income was -$80.6M. Statements: https://lician.com/financials/bioa

What is BIOA's latest diluted EPS?

Latest cached BioAge Labs, Inc (BIOA) diluted EPS for Dec 31, 2025 was -$2.24.

What period does the latest BIOA earnings print cover?

The latest cached BioAge Labs, Inc (BIOA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

Where are BIOA earnings listed?

Cached earnings facts for BioAge Labs, Inc (BIOA) are listed at https://lician.com/earnings/bioa. Statements: https://lician.com/financials/bioa

Not investment advice.

Full BIOA analysis